Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels

Journal of Clinical Neuroscience

Volumn 18, Issue 7, 2011, Pages 997-998

  Nakashima, Ichiro ^a,b   Takahashi, Toshiyuki ^a,c   Cree, Bruce A C ^d   Kim, Ho Jin ^e   Suzuki, Chihiro ^a   Genain, Claude P ^f   Vincent, Thierry ^g   Fujihara, Kazuo ^a   Itoyama, Yasuto ^a   Bar Or, Amit ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c Yonezawa National Hospital   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e National Cancer Center   (South Korea)

^f CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^g HÔPITAL SAINT ELOI   (France)

Author keywords

Anti aquaporin 4 antibody; B cell activating factor belonging to the TNF family; Neuromyelitis optica; Rituximab

Indexed keywords

AQUAPORIN 4 ANTIBODY; B CELL ACTIVATING FACTOR; PROTEIN ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELL ASSAY; CLINICAL ARTICLE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; B-CELL ACTIVATING FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROMYELITIS OPTICA;

EID: 79958112517     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.12.011     Document Type: Article

References (7)

1. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-7. (Pubitemid 41186945)
2. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008;131:3072-80.
3. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Annals of Neurology 2009;66:617-29.
4. Jacob A, Weinshenker BG, Violich I, et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008;65:1443-8.
5. Nagel A, Podstawa E, Eickmann M, et al. Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogenspecific IgG but not autoantibodies in pemphigus vulgaris. J Invest Dermatol 2009;129:2202-10.
6. Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000;404:995-9. (Pubitemid 30243593)
7. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1235-43. (Pubitemid 47355956)